Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast

Jul 27, 2022 4:05pm EDT

Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022

Jun 28, 2022 4:10pm EDT

Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure

Jun 28, 2022 4:05pm EDT

Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th

Jun 14, 2022 4:30pm EDT

Beyond Cancer™ Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer

Jun 01, 2022 7:00am EDT

Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022

May 17, 2022 4:05pm EDT

Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer

May 17, 2022 7:00am EDT

Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast

May 16, 2022 7:05am EDT

Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022

Apr 25, 2022 4:05pm EDT

Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022

Apr 25, 2022 7:00am EDT